Private Capital Group, LLC Biomarin Pharmaceutical Inc Transaction History

Private Capital Group, LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$71.72 - $91.47 $1,219 - $1,554	-17 Closed	0 $0
Q3 2021 Oct 13, 2021	SELL	$74.77 - $85.47 $897 - $1,025	-12 Reduced 41.38%	17 $1,000
Q2 2021 Jul 26, 2021	SELL	$75.51 - $84.79 $1,510 - $1,695	-20 Reduced 40.82%	29 $2,000
Q1 2021 Apr 12, 2021	SELL	$74.73 - $90.69 $2,540 - $3,083	-34 Reduced 40.96%	49 $4,000
Q4 2020 Jan 26, 2021	SELL	$72.61 - $90.2 $871 - $1,082	-12 Reduced 12.63%	83 $7,000
Q3 2020 Nov 12, 2020	BUY	$71.87 - $131.03 $574 - $1,048	8 Added 9.2%	95 $7,000
Q2 2020 Aug 13, 2020	SELL	$79.55 - $124.22 $636 - $993	-8 Reduced 8.42%	87 $11,000
Q1 2020 May 07, 2020	BUY	$71.37 - $96.85 $1,926 - $2,614	27 Added 39.71%	95 $8,000
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $4,049 - $5,441	-63 Reduced 48.09%	68 $5,000
Q3 2019 Nov 13, 2019	BUY	$67.4 - $85.11 $4,246 - $5,361	63 Added 92.65%	131 $9,000
Q2 2019 Aug 15, 2019	SELL	$80.35 - $93.9 $1,044 - $1,220	-13 Reduced 16.05%	68 $6,000
Q1 2019 Apr 26, 2019	BUY	$84.2 - $98.62 $84 - $98	1 Added 1.25%	81 $7,000
Q4 2018 Jan 28, 2019	BUY	$80.14 - $106.07 $961 - $1,272	12 Added 17.65%	80 $7,000
Q2 2018 Aug 09, 2018	BUY	$76.01 - $99.03 $1,900 - $2,475	25 Added 58.14%	68 $6,000
Q1 2018 May 16, 2018	SELL	$77.67 - $92.63 $190,835 - $227,591	-2,457 Reduced 98.28%	43 $3,000
Q4 2017 May 18, 2018	BUY	$80.76 - $95.13 $194,227 - $228,787	2,405 Added 2531.58%	2,500 $16,000
Q4 2017 Mar 07, 2018	BUY	$80.76 - $95.13 $7,672 - $9,037	95	95 $7,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Capital Group, LLC with notifications on news.